The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study

Hijiya, N., Maschan, A., Rizzari, C., Shimada, H., Dufour, C., Goto, H., Kang, H. J., Guinipero, T., Karakas, Z., Bautista, F., Ducassou, S., Yoo, K. H., Zwaan, C. M., Millot, F., Patterson, B. C., Samis, J., Izquierdo, M., Titorenko, K., Li, S., & Sosothikul, D. (2023). The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study. Blood Advances, 7(23), 7279–7289. https://doi.org/10.1182/bloodadvances.2023010122
Authors:
Nobuko Hijiya
Alexey Maschan
Carmelo Rizzari
Hiroyuki Shimada
Carlo Dufour
Hiroaki Goto
Hyoung Jin Kang
Terri Guinipero
Zeynep Karakaş
Francisco Bautista
Stéphane Ducassou
Keon Hee Yoo
C. Michel Zwaan
Frédéric Millot
Briana C. Patterson
Jill Samis
Miguel Izquierdo
Ksenia Titorenko
Sai Li
Darintr Sosothikul
Affiliated Authors:
Nobuko Hijiya
Publication Type:
Article
Unique ID:
10.1182/bloodadvances.2023010122
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: